B-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern

Cornea

Volumn 31, Issue 7, 2012, Pages 804-809

  Hajrasouliha, Amir R ^a   Sadrai, Zahra ^a   Chauhan, Sunil K ^a   Dana, Reza ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

corneal angiogenesis; fibroblast growth factor; vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CORNEA; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIGENS, CD31; BIOLOGICAL MARKERS; CORNEA; CORNEAL NEOVASCULARIZATION; DRUG IMPLANTS; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; LIGANDS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MICE; MICE, INBRED BALB C; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862834034     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31823f8b5a     Document Type: Article

References (30)

1. Dana R. Angiogenesis and lymphangiogenesis-implications for corneal immunity. Semin Ophthalmol. 2006;21:19-22.
2. Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy. 2007;92:50-57. (Pubitemid 47096896)
3. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int. 1995;19:431-444.
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4-25. (Pubitemid 27076453)
5. Alitalo K, Carmeliet P. Molecular mechanism of lymphangiogenesis in health and disease. Cancer Cell. 2002;1:219-227. (Pubitemid 41039145)
6. Björndahl MA, Cao R, Burton JB, et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 2005;65:9261-9268. (Pubitemid 41507992)
7. Cao R, Björndahl MA, Religa P, et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 2004;6:333-345. (Pubitemid 39361435)
8. Thurston G. Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 2003;314:61-68. (Pubitemid 37409913)
9. Veikkola T, Alitalo K. Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis. Dev Cell. 2002;3:302-304.
10. Tammela T, Saaristo A, Lohela M, et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood. 2005;105:4642-4648. (Pubitemid 40807283)
11. Morisada T, Oike Y, Yamada Y, et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood. 2005;105:4649-4656. (Pubitemid 40807284)
12. Cao Y, Zhong W. Tumor-derived lymphangiogenic factors and lymphatic metastasis. Biomed Pharmacother. 2007;61:534-539. (Pubitemid 47562689)
13. Rossant J, Hirashima M. Vascular development and patterning: making the right choices. Curr Opin Genet Dev. 2003;13:408-412. (Pubitemid 36897805)
14. Cursiefen C, Maruyama K, Jackson DG, et al. Time course of angiogen-esis and lymphangiogenesis after brief corneal inflammation. Cornea. 2006;25:443-447. (Pubitemid 44620130)
15. Bock F, Onderka J, Dietrich T, et al. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovas-cularisation. Graefes Arch Clin Exp Ophthalmol. 2008;246:115-119. (Pubitemid 350162691)
16. Chung ES, Saban DR, Chauhan SK, et al. Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci. 2009;50:1613-1618.
17. Dietrich T, Onderka J, Bock F, et al. Inhibition of inflammatory lym-phangiogenesis by integrin alpha5 blockade. Am J Pathol. 2007;171: 361-372. (Pubitemid 47339252)
18. Kenyon BM, Voest EE, Chen CC, et al. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci. 1996;37:1625-1632. (Pubitemid 26271414)
19. Murakami M, Simons M. Fibroblast growth factor regulation of neo-vascularization. Curr Opin Hematol. 2008;15:215-220. (Pubitemid 351507574)
20. Thomas KA, Riley MC, Lemmon SK, et al. Brain fibroblast growth factor: nonidentity with myelin basic protein fragments. J Biol Chem. 1980;255:5517-5520. (Pubitemid 10023581)
21. Itoh N. The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. Biol Pharm Bull. 2007;30:1819-1825. (Pubitemid 47607758)
22. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibro-blast growth factor receptors. Cytokine Growth Factor Rev. 2005;16: 139-149. (Pubitemid 40616112)
23. Ortega S, Ittmann M, Tsang SH, et al. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A. 1998;95:5672-5677. (Pubitemid 28224154)
24. Zhou M, Sutliff RL, Paul RJ, et al. Fibroblast growth factor 2 control of vascular tone. Nat Med. 1998;4:201-207. (Pubitemid 28137375)
25. Miller DL, Ortega S, Bashayan O, et al. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol Cell Biol. 2000;20: 2260-2268. (Pubitemid 30123841)
26. Magnusson P, Rolny C, Jakobsson L, et al. Deregulation of Flk-1/vascular endothelial growth factor receptor-2 in fibroblast growth factor receptor-1-deficient vascular stem cell development. J Cell Sci. 2004;117(pt 8): 1513-1523. (Pubitemid 38559826)
27. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth factor receptore-3 mediates induction of corneal alloimmunity. Nat Med. 2004; 10:813-815. (Pubitemid 39070853)
28. Goyal S, Chauhan SK, El Annan J, et al. Evidence of corneal lymphan-giogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol. 2010;128:819-824.
29. Hill JC. High risk corneal grafting. Br J Ophthalmol. 2002;86:945. (Pubitemid 34953600)
30. Peedo BB, Fagerholm P, Traneus-Röckert C, et al. Cellular-level characterization of lymph vessels in live, unlabeled corneas by in vivo con-focal microscopy. Invest Ophthalmol Vis Sci. 2010;51:830-835.